Made-in-Calgary drug to treat COVID-19 organ inflammation joins national trial

A Calgary-made drug designed to reduce organ inflammation in COVID-19 patients is entering a national human trial, with a study into its effectiveness set to begin at 65 hospitals across Canada. Read More

from Calgary Herald https://ift.tt/3IeFtlN
https://ift.tt/eA8V8J
Share:

Post a Comment

Note: Only a member of this blog may post a comment.

Copyright © Canada94news. Designed by OddThemes